937593-41-4 Usage
Uses
Used in Pharmaceutical Industry:
PYRIMIDINE-2-BORONIC ACID PINACOL ESTER is used as a key reactant in the synthesis of various pharmaceutical compounds. Its ability to form stable intermediates and participate in palladium-catalyzed coupling reactions makes it a valuable component in the creation of new drug candidates with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical field, PYRIMIDINE-2-BORONIC ACID PINACOL ESTER is utilized as a starting material for the preparation of agrochemical compounds. Its reactivity and stability contribute to the development of effective pesticides and other agricultural chemicals designed to protect crops and enhance agricultural productivity.
Used in Medicinal Chemistry Research:
PYRIMIDINE-2-BORONIC ACID PINACOL ESTER is employed as a versatile building block in medicinal chemistry research. It aids in the exploration of structure-activity relationships, facilitating the design and optimization of biologically active molecules with potential applications in treating various diseases and conditions.
Used in Drug Discovery:
PYRIMIDINE-2-BORONIC ACID PINACOL ESTER plays a crucial role in drug discovery, serving as a precursor for the development of new chemical entities. Its unique properties enable the synthesis of diverse molecular structures, which can be further modified and optimized to enhance their pharmacological properties and therapeutic potential.
Check Digit Verification of cas no
The CAS Registry Mumber 937593-41-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,7,5,9 and 3 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 937593-41:
(8*9)+(7*3)+(6*7)+(5*5)+(4*9)+(3*3)+(2*4)+(1*1)=214
214 % 10 = 4
So 937593-41-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H15BN2O2/c1-9(2)10(3,4)15-11(14-9)8-12-6-5-7-13-8/h5-7H,1-4H3
937593-41-4Relevant academic research and scientific papers
NEW COMPOUNDS
-
Page/Page column 183-184, (2008/06/13)
This invention relates to novel compounds having the structural formula I below: and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.
